Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Rapid Molecular Diagnostics for Acute Myeloid Leukemia Using Single-Molecule Sequencing

Esko A. Kautto, BS, Charles Thomas Gregory, BS, Caner Saygin, MD, Shelley Orwick, BS, James S. Blachly, MD

Blood (2019) 134 (Supplement_1): 374.

https://doi.org/10.1182/blood-2019-131366

Published: 2019

Journal Articles

Platelet Counts and Outcomes in Acute General Pediatric Patients

Jonathan Bardahl, DO, Pedro De Alarcon, MD

Blood (2019) 134 (Supplement_1): 5861.

https://doi.org/10.1182/blood-2019-131263

Published: 2019

Journal Articles

Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era

Naveen Pemmaraju, MD, Theresa Clementi, Wei Qiao, PhD, Susan K Peterson, PhD, Vicky Zoeller, Andrew J. Schorr, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1670.

https://doi.org/10.1182/blood-2019-129545

Published: 2019

Journal Articles

Health Care Utilization and Costs Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors

Joanna C Huang, PharmD, Sudeep Karve, PhD, Sanchita Porwal, BS, Kushan Thakkar, MS, Thomas Marshall, PharmD, MS, Tanja Rosenberg, MD

Blood (2018) 132 (Supplement 1): 3537.

https://doi.org/10.1182/blood-2018-99-113809

Published: 2018

Journal Articles

Use of Bone-Modifying Agents and Outcomes of Myeloma Therapy: A Population-Based Study

Adam J Olszewski, MD, Peter Barth, MD, John L. Reagan, MD

Blood (2018) 132 (Supplement 1): 709.

https://doi.org/10.1182/blood-2018-99-110739

Published: 2018

Journal Articles

Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax (VEN) or Chemotherapy (CT)/Chemoimmunotherapy (CIT)

Chadi Nabhan, MD, Anthony R. Mato, MD MSCE, Jonathan K. Kish, PhD MPH, Damion Nero, PhD

Blood (2018) 132 (Supplement 1): 4758.

https://doi.org/10.1182/blood-2018-99-118904

Published: 2018

Journal Articles

Healthcare Resource Utilization and Costs Associated with Different Treatment Modalities of Relapsed/Refractory Multiple Myeloma Patients in the US: Findings from Preamble

David J Kuter, MD DPhil, Clara Chen, PhD BS, MS, Sergey Popov, Catherine Davis, Ravi Vij, MD MBBS

Blood (2017) 130 (Supplement 1): 3157.

https://doi.org/10.1182/blood.V130.Suppl_1.3157.3157

Published: 2017

Journal Articles

Healthcare Burden of Patients with Follicular Lymphoma (FL) in Routine Clinical Care in the United States

Aaron Galaznik, MD, Jill A Bell, PhD, Laurie Hamilton, MS, Augustina Ogbonnaya, MPH, Kristin Hennenfent, PharmD, Michael T. Eaddy, PharmD, PhD, Yaping Shou, MD PhD

Blood (2017) 130 (Supplement 1): 2183.

https://doi.org/10.1182/blood.V130.Suppl_1.2183.2183

Published: 2017

Journal Articles

Economic Impact and Healthcare Utilization in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Routine Clinical Care in the United States (US) - a Claims Database Study

Aaron Galaznik, MD, Jill A Bell, PhD, Laurie Hamilton, MS, Augustina Ogbonnaya, MPH, Kristin Hennenfent, PharmD, Michael T. Eaddy, PharmD, PhD, Yaping Shou, MD PhD

Blood (2017) 130 (Supplement 1): 2185.

https://doi.org/10.1182/blood.V130.Suppl_1.2185.2185

Published: 2017

Journal Articles

Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Front-Line Ibrutinib or Chemoimmunotherapy

Chadi Nabhan, MD MBA, FACP, Jessica Chung, PhD MPH, Anthony R. Mato, MD, Jonathan Kish, PhD MPH, Damion Nero, PhD

Blood (2017) 130 (Supplement 1): 2111.

https://doi.org/10.1182/blood.V130.Suppl_1.2111.2111

Published: 2017

Journal Articles

Economic Burden of Treatment Episodes in Acute Myeloid Leukemia (AML) Patients in the US: A Retrospective Analysis of a Commercial Payer Database

Bruno C Medeiros, MD, Bhavik J Pandya, PharmD, Chi-Chang Chen, PhD, Eric S. Groves, MD PhD, Cat N. Bui, PhD, Laura Elise Horvath, MD, Rolin L. Wade, RpH, MS

Blood (2017) 130 (Supplement 1): 4694.

https://doi.org/10.1182/blood.V130.Suppl_1.4694.4694

Published: 2017

Journal Articles

Real-World Trends in Treatment Use, Healthcare Costs, and Overall Survival Among Patients with Multiple Myeloma

Rafael Fonseca, Safiya Abouzaid, Machaon Bonafede, Qian Cai, Kejal Parikh, Leon Cosler, Paul Richardson

Blood (2016) 128 (22): 3558.

https://doi.org/10.1182/blood.V128.22.3558.3558

Published: 2016

Journal Articles

Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States

Matthew J. Matasar, MD MS, Stacey Dacosta Byfield, PhD MPH, Cori Blauer-Peterson, MPH, Melissa Montez, PharmD, Carolina Reyes, PhD, Anthony Masaquel, PhD MPH

Blood (2016) 128 (22): 5928.

https://doi.org/10.1182/blood.V128.22.5928.5928

Published: 2016

Journal Articles

Minimal Hematology Analyzer Plus Blood Smear Digital Imaging/ Analysis Provides Better Clinical Hematology Results Than a Complex Hematology Analyzer Alone

H. Elizabeth Broome, MD, Han-Inge Bengtsson, MSc, Laura Stephens, MD, Lisa Palm

Blood (2016) 128 (22): 4731.

https://doi.org/10.1182/blood.V128.22.4731.4731

Published: 2016

Journal Articles

Real-World Clinical and Economic Burden of Hematopoietic Cell Transplantation Among a Large US Commercially Insured Populationhematopoietic CELL Transplantation Among a Large US Commercially Insured Population

Neil C Josephson, MD, Phillip M. Garfin, MDPhD, Akshara Richhariya, PhD, Machaon Bonafede, McMorrow Donna, Qian Cai, Miguel Perales, MD

Blood (2016) 128 (22): 2368.

https://doi.org/10.1182/blood.V128.22.2368.2368

Published: 2016

Journal Articles

Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma

Thomas W. LeBlanc, MD MA, Robert C Wolf, PharmD, Ellen Neylon, NP, Valerie Caroselli, Katie Deering, Brad Schenkel, MSc

Blood (2015) 126 (23): 5634.

https://doi.org/10.1182/blood.V126.23.5634.5634

Published: 2015

Journal Articles

Healthcare Utilization and Costs Among Patients with Hairy Cell Leukemia: Analysis of a Large US Administrative Claims Database

Victoria Divino, BA, Sudeep Karve, PhD, Andrew Gaughan, MSc, Mitch DeKoven, MHSA, Guozhi Gao, Mark Lanasa, MD PhD

Blood (2015) 126 (23): 4520.

https://doi.org/10.1182/blood.V126.23.4520.4520

Published: 2015

Journal Articles

Are There Differences in Treatment Patterns, Cost, and Quality Indicators By Site of Care for First Line Treatment for Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia (NHL/CLL)?

Adrianne W Casebeer, MPP, MS, PhD, Sari Hopson, MSPH, PhD, Dana A Drzayich Jankus, MS, Zhuliang Tao, MSPH, Stephen Stemkowski, MHA, PhD, Andrew Howe, PharmD, BA, Jeffrey Patton, MD, Art Small, MD, Anthony Masaquel, MPH, PhD

Blood (2015) 126 (23): 3298.

https://doi.org/10.1182/blood.V126.23.3298.3298

Published: 2015

Journal Articles

Annual Patient and Caregiver Burden of Oncology Clinic Visits for Granulocyte-Colony Stimulating Factor (G-CSF) Therapy in the United States (US)

Mark Stephens, Xiaoyan Li, PhD, Maureen Reiner, Wayne Sheldon, Spiros Tzivelekis, MSc

Blood (2015) 126 (23): 2066.

https://doi.org/10.1182/blood.V126.23.2066.2066

Published: 2015

Journal Articles

Healthcare Resource Utilization and Costs Among Patients with Myelodysplastic Syndrome Who Failed 1 st -Line Therapy

Christopher R. Cogle, MD, Sudipto Mukherjee, MD MPH, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS

Blood (2014) 124 (21): 2627.

https://doi.org/10.1182/blood.V124.21.2627.2627

Published: 2014

NARROW

Rapid Molecular Diagnostics for Acute Myeloid Leukemia Using Single-Molecule Sequencing

Platelet Counts and Outcomes in Acute General Pediatric Patients

Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era

Health Care Utilization and Costs Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors

Use of Bone-Modifying Agents and Outcomes of Myeloma Therapy: A Population-Based Study

Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax (VEN) or Chemotherapy (CT)/Chemoimmunotherapy (CIT)

Healthcare Resource Utilization and Costs Associated with Different Treatment Modalities of Relapsed/Refractory Multiple Myeloma Patients in the US: Findings from Preamble

Healthcare Burden of Patients with Follicular Lymphoma (FL) in Routine Clinical Care in the United States

Economic Impact and Healthcare Utilization in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Routine Clinical Care in the United States (US) - a Claims Database Study

Comparison of Costs and Health Care Resource Utilization (HRU) in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Front-Line Ibrutinib or Chemoimmunotherapy

Economic Burden of Treatment Episodes in Acute Myeloid Leukemia (AML) Patients in the US: A Retrospective Analysis of a Commercial Payer Database

Real-World Trends in Treatment Use, Healthcare Costs, and Overall Survival Among Patients with Multiple Myeloma

Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States

Minimal Hematology Analyzer Plus Blood Smear Digital Imaging/ Analysis Provides Better Clinical Hematology Results Than a Complex Hematology Analyzer Alone

Real-World Clinical and Economic Burden of Hematopoietic Cell Transplantation Among a Large US Commercially Insured Populationhematopoietic CELL Transplantation Among a Large US Commercially Insured Population

Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma

Healthcare Utilization and Costs Among Patients with Hairy Cell Leukemia: Analysis of a Large US Administrative Claims Database

Are There Differences in Treatment Patterns, Cost, and Quality Indicators By Site of Care for First Line Treatment for Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia (NHL/CLL)?

Annual Patient and Caregiver Burden of Oncology Clinic Visits for Granulocyte-Colony Stimulating Factor (G-CSF) Therapy in the United States (US)

Healthcare Resource Utilization and Costs Among Patients with Myelodysplastic Syndrome Who Failed 1 st -Line Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only